The PI3K/Akt/mTOR Pathway: Immuno-Metabolic Orchestration in IR/MASH-Associated Hepatocellular Carcinoma

Jian Zhao(Quzhou City People's Hospital), Yongsheng Wang(Lanzhou University of Technology), Lei Sun(Weifang Medical University), Dan Li(Shanghai Jiao Tong University), Zhigong Wei(Sichuan University), Kai Li(Sichuan University)
International Journal of Biological Sciences
September 27, 2025
10.7150/ijbs.120657
Cited by 12

Related Papers

Phase Separation of Disease-Associated SHP2 Mutants Underlies MAPK Hyperactivation
|Cell|2020|274
Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly
|Nature Communications|2019|225
Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson’s disease familial A53T mutation
|Cell Research|2020|149
Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure
|Nature Communications|2020|141
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
|BMJ|2023|82